Juvenile Diabetes

Current news and events relating to Juvenile Diabetes, also known as type 1 diabetes, including research, studies, treatments, potential cures and more.

Revised Definition Means Millions More Have Pre-Diabetes

Pre-diabetes - a condition that raises a person's risk of developing type 2 diabetes, heart disease, and stroke - is far more common in America than previously believed.

Type 1 Diabetics’ Blood Sugar Defense Mechanisms Restored After Islet Cell Transplantation

Type 1 diabetics who have developed low blood sugar (hypoglycemia) as a complication of insulin treatments over time are able to regain normal internal recognition of the condition after receiving pancreatic islet cell transplantation.

BCG Vaccine for Tuberculosis May Cure Type 1 Diabetes

Exciting news for people with Type 1 Diabetes. Bacillus Calmette-Guérin (BCG), a generic drug with over 90 years of clinical use and safety data,...

Replacements for Harmful Chemicals in Plastics are Just as Bad, Increasing Risk of Diabetes...

New study shows that two of the chemicals that are increasingly being used to make everything from plastic wrap and food containers to cosmetics...

Children with Fatter Midsection at Increased Risk for Cardiovascular Disease

Children with more fat around their midsections could be at a higher risk of developing cardiovascular disease later in life, researchers say.

Scientists Turn Human Skin Cells Into Insulin-producing Cells

Researchers have transformed cells from human skin into cells that produce insulin, the hormone used to treat diabetes. The breakthrough may one day lead to new treatments or even a cure for the millions of people affected by the disease, researchers say.

High Rate of Overweight and Obesity Found in Children Having Surgery

A very high proportion of children who are having surgery are overweight or obese, and because of the excess weight have a greater chance of experiencing problems associated with the surgery, according to a new study.

High-Sugar Diet Pushing Some Latino Kids Toward Type 2 Diabetes

Overweight Latino children who consume lots of sugar-especially in sugary drinks-show signs of beta cell decline, a precursor of type 2 diabetes, according to researchers.
Picture of Dr. Beyerlein & Prof. Dr. Ziegler

Infections Can Increase Risk of Diabetes in Children

A recently published study details how a certain type of infection in infants is associated with a greater risk of developing type 1 diabetes. Viral...
Pollution Affects Blood Sugar Levels and Cholesterol

Air Pollution Linked to Poorer Blood Sugar and Cholesterol

Exposure to air pollution has an especially negative impact on people with diabetes, which includes worsening blood sugar levels. Exposure to air pollution can worsen...

Adult Stem Cells Selectively Delivered Into The Eye and Used to Control Angiogenesis

A team of researchers has discovered a way to use adult bone marrow stem cells to form new blood vessels in the eye or to deliver chemicals that will prevent the abnormal formation of new vessels.
Children with Diabetes - More Kids Being Diagnosed with Type 1 and 2 Diabetes

More Kids Being Diagnosed with Type 1 and Type 2 Diabetes

Rates of newly diagnosed cases of type 1 and 2 diabetes is on the rise among children and teens, with the fastest rise seen...

Diabetic Enteropathy Cause, Treatment and Possible Prevention Discovered

Diabetic enteropathy - with gastrointestinal symptoms like abdominal pain, bloating and nausea - may soon be preventable and treatable. Exciting news considering that it...

Found: A Gene That May Play a Role in Type 1 Diabetes

Scientists have identified a gene that may play a role in the development of type 1 diabetes.

Metabolic Syndrome Affects Nearly 1 in 10 US Teens

About nine percent of teenagers may have metabolic syndrome, a clustering of risk factors that put them on the path toward heart disease and diabetes in adulthood.

Type 1 Diabetes Safely Arrested With Short-Term Use of New Drug

Researchers have halted the course of early stage Type 1 diabetes for a year by treating patients for just two weeks with a new immune-suppressive drug, which only had minor side effects.